T1	CHEM 19 49	lipoproteínas de alta densidad
#1	AnnotatorNotes T1	C0023821; High Density Lipoproteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T2	PROC 55 67	intervención
#2	AnnotatorNotes T2	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T3	CHEM 72 91	esteroles vegetales
#3	AnnotatorNotes T3	C0031866; phytosterols; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T4	DISO 109 128	hipercolesterolemia
#4	AnnotatorNotes T4	C0020443; Hypercholesterolemia; Disease or Syndrome
T5	CHEM 227 237	colesterol
#5	AnnotatorNotes T5	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T6	DISO 307 328	riesgo cardiovascular
#6	AnnotatorNotes T6	C4324389; Cardiovascular Risk; Finding
T7	CHEM 1543 1548	HDL-c
#7	AnnotatorNotes T7	C0023822; High Density Lipoprotein Cholesterol; Organic Chemical · Biologically Active Substance
T8	ANAT 314 328	cardiovascular
#8	AnnotatorNotes T8	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T9	CHEM 389 406	apolipoproteína A
#9	AnnotatorNotes T9	C0003592; Apolipoproteins A; Amino Acid, Peptide, or Protein · Biologically Active Substance
T10	CHEM 408 413	ApoA1
#10	AnnotatorNotes T10	C0085201; Apolipoprotein A-I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T11	ANAT 475 489	cardiovascular
#11	AnnotatorNotes T11	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T12	CHEM 554 564	colesterol
#12	AnnotatorNotes T12	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T13	PROC 646 699	ensayo clínico, controlado, aleatorizado, doble ciego
#13	AnnotatorNotes T13	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T14	CHEM 1594 1599	ApoA1
#14	AnnotatorNotes T14	C0085201; Apolipoprotein A-I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T15	CHEM 740 749	esteroles
#15	AnnotatorNotes T15	C0038323; Sterols; Organic Chemical
T16	PROC 792 799	placebo
#16	AnnotatorNotes T16	C0032042; Placebos; Therapeutic or Preventive Procedure
T17	PROC 859 881	estudio antropométrico
T18	CHEM 1035 1042	esterol
#17	AnnotatorNotes T18	C0038323; Sterols; Organic Chemical
T19	PROC 1048 1055	placebo
#18	AnnotatorNotes T19	C0032042; Placebos; Therapeutic or Preventive Procedure
T20	DISO 468 489	riesgo cardiovascular
#19	AnnotatorNotes T20	C4324389; Cardiovascular Risk; Finding
T21	CHEM 1142 1147	LDL-c
#20	AnnotatorNotes T21	C0023824; LDL Cholesterol Lipoproteins; Organic Chemical · Biologically Active Substance
T22	PROC 1250 1262	intervención
#21	AnnotatorNotes T22	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T23	ANAT 1575 1589	cardiovascular
#22	AnnotatorNotes T23	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T24	ANAT 1676 1683	corazón
#23	AnnotatorNotes T24	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T25	DISO 1710 1731	riesgo cardiovascular
#24	AnnotatorNotes T25	C4324389; Cardiovascular Risk; Finding
T26	ANAT 1717 1731	cardiovascular
#25	AnnotatorNotes T26	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T27	CHEM 10 15	ApoA1
#26	AnnotatorNotes T27	C0085201; Apolipoprotein A-I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T28	PROC 210 237	concentración de colesterol
T29	CHEM 249 293	lipoproteínas de alta densidad de colesterol
T30	CHEM 295 300	HDL-c
#27	AnnotatorNotes T30	C0023822; High Density Lipoprotein Cholesterol; Biologically Active Substance · Organic Chemical
T31	CHEM 420 425	HDL-C
#28	AnnotatorNotes T31	C0023822; High Density Lipoprotein Cholesterol; Organic Chemical · Biologically Active Substance
T32	CHEM 526 531	ApoA1
#29	AnnotatorNotes T32	C0085201; Apolipoprotein A-I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T33	CHEM 600 605	HDL-c
#30	AnnotatorNotes T33	C0023822; High Density Lipoprotein Cholesterol; Organic Chemical · Biologically Active Substance
T34	PROC 823 835	cuestionario
#31	AnnotatorNotes T34	C2960239; Assessment using health assessment questionnaire; Health Care Activity | C1882515; Questionnaire Administration; Health Care Activity
T35	CHEM 1095 1140	lipoproteínas de baja densidad del colesterol
T36	CHEM 1207 1212	ApoA1
#33	AnnotatorNotes T36	C0085201; Apolipoprotein A-I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T37	CHEM 1199 1204	HDL-C
#34	AnnotatorNotes T37	C0023822; High Density Lipoprotein Cholesterol; Organic Chemical · Biologically Active Substance
T38	CHEM 1468 1473	ApoA1
#35	AnnotatorNotes T38	C0085201; Apolipoprotein A-I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T39	CHEM 1460 1465	HDL-c
#36	AnnotatorNotes T39	C0023822; High Density Lipoprotein Cholesterol; Organic Chemical · Biologically Active Substance
T40	PROC 1532 1548	niveles de HDL-c
#37	AnnotatorNotes T40	C0392885; High density lipoprotein measurement; Laboratory Procedure
T41	LIVB 95 104	pacientes
#38	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T46	PHYS 538 564	metabolismo del colesterol
#39	AnnotatorNotes T46	C1156530; Cholesterol metabolism; Molecular Function
T47	LIVB 612 634	población adulta joven
#40	AnnotatorNotes T47	C1257890; Population; Population Group + C0001675; Adult; Age Group + C0087178; Youth; Age Group
T49	Duration 771 780	3 semanas
T42	PHYS 1664 1683	función del corazón
#41	AnnotatorNotes T42	C0232164; Cardiac function; Organ or Tissue Function
A1	Population_data T47 Age
T43	Spec_cue 363 370	posible
T44	CONC 371 379	relación
A2	Assertion T44 Speculated
R1	Speculation Arg1:T43 Arg2:T44	
R2	Used_for Arg1:T3 Arg2:T2	
R3	Experiences Arg1:T41 Arg2:T4	
R4	Experiences Arg1:T41 Arg2:T2	
R5	Experiences Arg1:T41 Arg2:T27	
R6	Location_of Arg1:T8 Arg2:T6	
R7	Location_of Arg1:T11 Arg2:T20	
R10	Used_for Arg1:T12 Arg2:T46	
T48	Observation 516 522	efecto
#43	AnnotatorNotes T48	C1518681; Outcome of Therapy; Finding (?)
R11	Causes Arg1:T32 Arg2:T48	
R12	Experiences Arg1:T47 Arg2:T32	
R13	Experiences Arg1:T47 Arg2:T48	
R14	Experiences Arg1:T47 Arg2:T46	
R16	Overlap Arg1:T48 Arg2:T33	
R17	Overlap Arg1:T32 Arg2:T33	
#44	AnnotatorNotes T28	C0201950; Cholesterol measurement test; Laboratory Procedure
R19	Overlap Arg1:T28 Arg2:T29	
R20	Overlap Arg1:T28 Arg2:T30	
R21	Overlap Arg1:T9 Arg2:T31	
R22	Overlap Arg1:T10 Arg2:T31	
T50	Food 720 725	leche
#45	AnnotatorNotes T50	C2825079; Milk - dietary; Food
R23	Combined_with Arg1:T50 Arg2:T15	
R24	Has_Duration_or_Interval Arg1:T50 Arg2:T49	
R25	Has_Duration_or_Interval Arg1:T15 Arg2:T49	
R26	Has_Duration_or_Interval Arg1:T16 Arg2:T49	
#46	AnnotatorNotes T17	C0003188; Anthropometry; Research Activity
T51	Quantifier_or_Qualifier 882 890	completo
#47	AnnotatorNotes T51	C0205197; Complete; Qualitative Concept
R27	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T51	
T52	Food 1026 1031	leche
#48	AnnotatorNotes T52	C2825079; Milk - dietary; Food
R28	Combined_with Arg1:T52 Arg2:T18	
R29	Overlap Arg1:T52 Arg2:T35	
R30	Overlap Arg1:T52 Arg2:T21	
R31	Overlap Arg1:T19 Arg2:T35	
R32	Overlap Arg1:T19 Arg2:T21	
T53	CONC 1264 1285	correlación de Person
#49	AnnotatorNotes T53	C0871052; Pearson Correlation Coefficient; Quantitative Concept | C1709490; Pearson Correlation Test; Intellectual Product
T54	CONC 1355 1371	regresión lineal
#50	AnnotatorNotes T54	C0023733; Linear Regression; Quantitative Concept
T55	CONC 1238 1262	final de la intervención
T56	CONC 1223 1232;1244 1262	principio de la intervención
T57	Observation 1569 1589	salud cardiovascular
R33	Location_of Arg1:T23 Arg2:T57	
R35	Location_of Arg1:T24 Arg2:T42	
R38	Location_of Arg1:T26 Arg2:T25	
#32	AnnotatorNotes T35	C0023824; LDL Cholesterol Lipoproteins; Organic Chemical · Biologically Active Substance
#42	AnnotatorNotes T44	C0439849; Relationships; Qualitative Concept
#51	AnnotatorNotes T29	C0023822; High Density Lipoprotein Cholesterol; Biologically Active Substance · Organic Chemical
A3	Experiencer T47 Patient
A4	Experiencer T41 Patient
